We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
WEZLANA ustekinumab 5 mg / 1.0 mL (130 mg/26 mL) solution for intravenous infusion injection vial (2024-25)
Product name
WEZLANA ustekinumab 5 mg / 1.0 mL (130 mg/26 mL) solution for intravenous infusion injection vial
Sponsor name
Amgen Australia Pty Ltd
Year Range
2024-25